TUMS Antacid Tablets Recalled for Glass Mineral Wool Contamination
TUMS Antacid chewable tablets (Assorted Berries, 1000 mg, lot HR5W) are being recalled nationwide because some bottles contain glass mineral wool. Consumers should stop using affected bottles immediately.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall involving glass mineral wool contamination, which poses a significant risk of physical injury if ingested. No illnesses or injuries have been reported in the source text, which limits the score to High per the rubric.
Plain-English summary
TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, chewable tablets packaged in 72-count bottles (NDC 135-0181-02) are being recalled nationwide by GlaxoSmithKline Consumer Healthcare Holdings LLC.
The affected product lot HR5W with an expiration date of 09/30/2027 may contain glass mineral wool, a foreign substance that could pose a serious health risk if ingested.
Consumers who have purchased this product with lot number HR5W should stop using it immediately and discard the affected bottles. This is a Class II recall issued by the FDA.
The recalled product
- Product
- TUMS Antacid, Calcium Carbonate USP 1000 mg, Assorted Berries flavor, Chewable Tablets, packaged in 72-count bottles, Dist. by: GSK CH, Warren, NJ 07059. NDC: 135-0181-02, UPC 3-0766-0746-50-8
- Manufacturer
- GlaxoSmithKline Consumer Healthcare Holdings LLC
- Category
- Drug
- Hazard
- glass-mineral-wool
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: HR5W
- Exp. Date 09/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01